Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection
Clinical trial NCT04350138 · COMPLETED
Trial details
- NCT number
- NCT04350138
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2026-02-18
- Enrollment
- 2606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.